Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Immunomedics’ Epratuzumab Enters Phase III Trials For Lupus

Related Content

La Jolla Proceeds With Additional Riquent Dosing Study

Nov 23 2004

Genelabs' Prestara Phase III Does Not Confirm Bone Mineral Density Effect

Oct 05 2004

Lupus Guidance Suggests Broad Use Of Health-Related Quality Of Life Endpoint

Mar 28 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window